Literature DB >> 17351762

Influence of CCR5-Delta32 genotype in Spanish population with multiple sclerosis.

D Otaegui1, J Ruíz-Martínez, J Olaskoaga, J I Emparanza, A López de Munain.   

Abstract

A number of association studies have explored the relationship between the CCR5-Delta32 allele and the risk of developing multiple sclerosis (MS), with varying results. In light of the results of several studies that have analyzed the role of the allele in MS, it has been proposed that the allele is involved in the etiopathogeny of the disease. Our study revealed a statistically significant difference between the study group and the control group for the carriers of at least one deleted allele (P = 0.027). The allele was more frequent in the control group, which suggests a possible protective effect of this deletion against MS. When ethnic origin was taken into account in the same analysis, we saw that the bulk of the difference was attributable to the Basque group, although the trend was also visible in the control group. Consideration of ethnic origin is therefore essential for the analysis of our sample. CCR5-Delta32 allele distribution was higher in the Basque control population than in the Basque MS population, which suggests that it confers a protective effect against MS. Relevant values were a P value of 0.008 and an odds ratio of 0.168 (95% confidence interval, 0.038 to 0.737).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351762     DOI: 10.1007/s10048-007-0085-1

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   3.017


  35 in total

1.  Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.

Authors:  K Pulkkinen; M Luomala; H Kuusisto; T Lehtimäki; M Saarela; T O Jalonen; I Elovaara
Journal:  Acta Neurol Scand       Date:  2004-05       Impact factor: 3.209

2.  A full genome search in multiple sclerosis.

Authors:  G C Ebers; K Kukay; D E Bulman; A D Sadovnick; G Rice; C Anderson; H Armstrong; K Cousin; R B Bell; W Hader; D W Paty; S Hashimoto; J Oger; P Duquette; S Warren; T Gray; P O'Connor; A Nath; A Auty; L Metz; G Francis; J E Paulseth; T J Murray; W Pryse-Phillips; R Nelson; M Freedman; D Brunet; J P Bouchard; D Hinds; N Risch
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

3.  Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia.

Authors:  Borut Peterlin; Smiljana Ristić; Juraj Sepcić; Beatrika Koncan Vracko; Andreja Rako; Luca Lovrecić; Bojana Brajenović-Milić; Josip Rudez; Eris Materljan; Miljenko Kapović
Journal:  J Neurol Sci       Date:  2006-06-27       Impact factor: 3.181

4.  Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis.

Authors:  Eva Julià; Xavier Montalban; Hammad Al-Zayat; Shohreh Issazadeh-Navikas; Robert Goertsches; Roland Martin; Manuel Comabella
Journal:  J Neuroimmunol       Date:  2006-08-08       Impact factor: 3.478

5.  The prevalence of multiple sclerosis in the Sanitary District of Vélez-Málaga, southern Spain.

Authors:  O Fernández; G Luque; C San Román; M Bravo; G Dean
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

6.  CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

Authors:  J Reynes; P Portales; M Segondy; V Baillat; P André; O Avinens; M C Picot; J Clot; J F Eliaou; P Corbeau
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

7.  Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions.

Authors:  J E Simpson; J Newcombe; M L Cuzner; M N Woodroofe
Journal:  Neuropathol Appl Neurobiol       Date:  2000-04       Impact factor: 8.090

8.  Association of CCR5 delta32 deletion with early death in multiple sclerosis.

Authors:  Radhika Gade-Andavolu; David E Comings; James MacMurray; Masoud Rostamkhani; Li S-C Cheng; Wallace W Tourtellotte; Lawrence A Cone
Journal:  Genet Med       Date:  2004 May-Jun       Impact factor: 8.822

9.  Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.

Authors:  J A Silversides; S V Heggarty; G V McDonnell; S A Hawkins; C A Graham
Journal:  Mult Scler       Date:  2004-04       Impact factor: 6.312

10.  Three allele combinations associated with multiple sclerosis.

Authors:  Olga O Favorova; Alexander V Favorov; Alexey N Boiko; Timofey V Andreewski; Marina A Sudomoina; Alexey D Alekseenkov; Olga G Kulakova; Eugenyi I Gusev; Giovanni Parmigiani; Michael F Ochs
Journal:  BMC Med Genet       Date:  2006-07-26       Impact factor: 2.103

View more
  3 in total

1.  CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian population.

Authors:  Majid Shahbazi; Hamid Ebadi; Davood Fathi; Danial Roshandel; Mana Mahamadhoseeni; Azam Rashidbaghan; Narges Mahammadi; Mahammad Reza Mahammadi; Mahdi Zamani
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

2.  CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients.

Authors:  Rosalia D'Angelo; Concetta Crisafulli; Carmela Rinaldi; Alessia Ruggeri; Aldo Amato; Antonina Sidoti
Journal:  Mult Scler Int       Date:  2011-06-23

Review 3.  CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.

Authors:  Bruna Kulmann-Leal; Joel Henrique Ellwanger; José Artur Bogo Chies
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.